RAPT Therapeutics, Inc. Proceeds from Common Stock Issued
RAPT Therapeutics, Inc. reported Proceeds from Common Stock Issued of $8.96 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-03-06
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-09-30 was $0.00.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2021-06-30 was $133.40M.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2024 was $8.96M.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2023 was $0.00.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2020 was $73.61M, a 112.00% increase from fiscal 2019.
- RAPT Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2019 was $34.72M, a 12953.01% increase from fiscal 2018.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $8.96M 10-K · filed 2025-03-06 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $49.78M 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | $49.78M 10-Q · filed 2023-08-11 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $133.40M derived: sum of 2 quarters · filed 2022-11-10 | $134.58M 10-Q · filed 2022-11-10 | $138.35M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $133.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $134.58M 10-Q · filed 2022-08-11 | $138.35M derived: sum of 3 quarters · filed 2022-08-11 | $138.35M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $1.18M 10-Q · filed 2021-05-11 | $4.95M derived: sum of 2 quarters · filed 2021-05-11 | $4.95M derived: sum of 3 quarters · filed 2021-05-11 | $4.95M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2020-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.77M derived: sum of 2 quarters · filed 2021-03-11 | $3.77M derived: sum of 3 quarters · filed 2021-03-11 | $73.61M 10-K · filed 2021-03-11 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $69.84M 10-Q · filed 2020-11-16 | $104.56M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $69.84M 10-Q · filed 2020-08-13 | $104.56M derived: sum of 3 quarters · filed 2021-05-11 | $104.56M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2020-03-31 | $69.84M 10-Q · filed 2021-05-11 | $104.56M derived: sum of 2 quarters · filed 2021-05-11 | $104.56M derived: sum of 3 quarters · filed 2021-05-11 | $104.56M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $34.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $34.72M derived: sum of 2 quarters · filed 2021-03-11 | $34.72M derived: sum of 3 quarters · filed 2021-03-11 | $34.72M 10-K · filed 2021-03-11 | $802.00K 10-K · filed 2020-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | $782.00K 10-Q · filed 2019-12-11 | $68.00K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $68.00K derived: sum of 3 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $68.00K derived: sum of 2 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $266.00K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $198.00K 10-Q · filed 2019-12-11 |